MARCH 2024LIFE SCIENCES REVIEW5CXO INSIGHTSNicholas Smalley, Vice President of Regulatory Affairs, Kindeva Drug DeliveryFrom Complex to Compliance: 3 Keys for Unlocking the Regulatory Pathway24Safwan Kezbor, Senior Medical Director, Clinical Development Shionogi Inc.Accelerating Early-stage Drug Development28Marc de Garidel, CEO and Interim Chairman, AbivaxLeveraging Technological Advancements for Developing Innovative Therapeutics32Jacob Gronnegaard, Director Automation, FUJIFILM Diosynth BiotechnologiesModular approach for Large Scale Cell Culture CDMO facilities3618Facet Life SciencesKen VanLuvanee, President and CEO22GlemserKevin Morgan,CEOG. Alexander Fleming, Founder & Executive ChairmanThomas Seoh, CEO30Kinexum34MedPro SystemsGreg Ungemach,CEOTOP 10 SERVICES PROVIDERS - 2024REGULATORYAndreas Søderman, Head of Medical Affairs,OrifarmThe Untapped Potential of Medical Affairs in Generics, Value added medicines and Hybrid pharmaceuticals2026Global Pharma SolutionsMargaret Jenkins, Principal and Founder
< Page 4 | Page 6 >